Administration of Monoclonal Antibody for COVID-19 in Patient Homes.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34648014.
- Also identified by DOI 10.1001/jamanetworkopen.2021.29388 and PMC identifier 8517740.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines the outcomes of a program providing monoclonal antibody treatments to COVID-19–positive patients in their homes.
Medical subject headings
- Antibodies, Monoclonal
- COVID-19
- Home Care Services
- Immunologic Factors